Serving 500+ biopharmaceutical companies globally:

Baxter
McKinsey
Chubb
Argus Health
Queensland Health
Express Scripts
Moodys
Deloitte
Johnson and Johnson
Chinese Patent Office

Which pharmaceutical companies have the most SPCs in Slovakia?

This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Slovakia.

SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating for the long time needed to obtain regulatory approval for drugs. SPCs come into force only after the corresponding general patent expires, and normally have a maximum lifetime of 5 years.

The total combined duration of market exclusivity of a general patent and SPC cannot normally exceed 15 years, but a six-month extention may be obtained by responding to a request for pediatric trials.

For a different perspective, see the drug companies with SPCs in the most countries

The pharma companies with the most SPCs in Slovakia are:

Back to Pharmaceutical Industry Infographics

For more information try a trial or see the database preview and plans and pricing

botpot